{"id":3219,"date":"2013-07-09T06:30:00","date_gmt":"2013-07-09T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/"},"modified":"2013-07-09T06:30:00","modified_gmt":"2013-07-09T06:30:00","slug":"samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/","title":{"rendered":"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>I juni, enligt tidplan, var samtliga patienter inkluderade i den kliniska studien med STEEN Solution\u2122. Resultat hittills bekr\u00e4ftar tidigare erfarenheter fr\u00e5n enskilda center, att de lungor som initialt valts bort, men som sedan utv\u00e4rderats med Ex Vivo Lung Perfusion (EVLP) fungerar lika bra som de lungor som bed\u00f6mts som b\u00e4st, samt att anv\u00e4ndandet av EVLP f\u00f6r att utv\u00e4rdera den marginella donatorpoolen \u00e4r s\u00e4ker. Patienterna kommer att f\u00f6ljas under ett \u00e5r efter transplantation.<\/strong><\/div>\n<p><span>NOVEL studien \u00e4r en multicenter studie p\u00e5 6 center i USA och designades f\u00f6r att p\u00e5 ett s\u00e4kert s\u00e4tt \u00f6ka antalet anv\u00e4ndbara lungor fr\u00e5n donatorpoolen. I studien j\u00e4mf\u00f6rdes de kliniska resultaten efter ex-vivo lung perfusion (EVLP) av lungor som initialt valts bort eller marginella lungor med en kontrollgrupp best\u00e5ende av lungor som bed\u00f6mts som b\u00e4st och transplanterats direkt. Totalt 42 patienter genomgick transplantation efter STEEN Solution\u2122 metoden och dessa matchades med 42 patienter i en kontrollgrupp. De tidiga resultaten indikerar att lungor som initialt valts bort och som d\u00e4refter utv\u00e4rderats med STEEN Solution\u2122 fungerar lika bra som lungor vilka klassats som b\u00e4st och transplanterats direkt. Detta \u00e4r i linje med erfarenhet fr\u00e5n center i Europa och Kanada d\u00e4r EVLP med Steen Solution\u2122 redan \u00e4r i klinisk anv\u00e4ndning. <\/span><\/p>\n<p><span>P\u00e5 den internationella kongressen, International Society of Heart and Lung Transplantation (ISHLT) i Montr\u00e9al, presenterades resultaten hittills och bekr\u00e4ftade tidigare erfarenheter fr\u00e5n enskilda center d\u00e4r lungor som initialt valts bort, men sedan utv\u00e4rderats med Ex Vivo Lung Perfusion (EVLP) fungerar lika bra som de lungor som bed\u00f6mts som b\u00e4st och transplanterats direkt. Resultaten indikerar ocks\u00e5 att anv\u00e4ndandet av EVLP f\u00f6r att utv\u00e4rdera den marginella donatorpoolen \u00e4r s\u00e4ker. Vid samma konferens presenterades de samlade resultaten fr\u00e5n Toronto (Canada), Wien (\u00d6sterrike) och Paris (Frankrike) d\u00e4r man totalt utv\u00e4rderat 140 lungor och transplanterat 114 lungor. Mer \u00e4n 240 patienter har nu f\u00e5tt lungor utv\u00e4rderade med STEEN Solution\u2122 metoden, lungor som hade varit f\u00f6rblivit outnyttjade utan denna teknologi. <\/span><\/p>\n<p><span>\u201cDe kliniska resultaten fr\u00e5n studien \u00e4r v\u00e4ldigt upplyftande och visar att STEEN Solution\u2122 p\u00e5 ett s\u00e4kert s\u00e4tt kan ge fler tillg\u00e4ngliga organ f\u00f6r den h\u00e4r livr\u00e4ddande behandlingen av patienter med livshotande lungsjukdomar s\u00e4ger Dr Magnus Nilsson, VD p\u00e5 XVIVO Perfusion. <\/span><\/p>\n<p><span>G\u00f6teborg 9 juli 2013<br \/><\/span><span>XVIVO Perfusion AB (publ)<br \/><\/span><span>Magnus Nilsson<br \/><\/span><span>Verkst\u00e4llande direkt\u00f6r<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, tel: 031-788 21 59, e-post: <a href=\"mailto:christoffer.rosenblad@xvivperfusion.com\" rel=\"nofollow\">christoffer.rosenblad@xvivoperfusion.com<\/a><br \/>F\u00f6r ytterligare information om Xvivo Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, <a href=\"http:\/\/www.xvivoperfusion.com\" rel=\"nofollow\">www.xvivoperfusion.com<\/a><\/span><\/p>\n<p><span>Xvivo Perfusion\u00a0\u00e4r skyldigt att offentligg\u00f6ra informationen i detta pressmeddelande enligt lagen om v\u00e4rdepappersmarknaden och\/eller lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r publicering den\u00a09 juli 2013 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>I juni, enligt tidplan, var samtliga patienter inkluderade i den kliniska studien med STEEN Solution\u2122. Resultat hittills bekr\u00e4ftar tidigare erfarenheter&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3219","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO\" \/>\n<meta property=\"og:description\" content=\"I juni, enligt tidplan, var samtliga patienter inkluderade i den kliniska studien med STEEN Solution\u2122. Resultat hittills bekr\u00e4ftar tidigare erfarenheter...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\\\/\",\"name\":\"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2013-07-09T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/","og_locale":"en_US","og_type":"article","og_title":"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO","og_description":"I juni, enligt tidplan, var samtliga patienter inkluderade i den kliniska studien med STEEN Solution\u2122. Resultat hittills bekr\u00e4ftar tidigare erfarenheter...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/","name":"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122 - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2013-07-09T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/samtliga-patienter-inkluderade-i-den-amerikanska-novel-studien-med-steen-solution\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}